These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 365123)

  • 21. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Gross MD
    Pediatrics; 1976 Sep; 58(3):423-31. PubMed ID: 958770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of methylphenidate on the mother-child interactions of hyperactive children.
    Barkley RA; Cunningham CE
    Arch Gen Psychiatry; 1979 Feb; 36(2):201-8. PubMed ID: 369470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
    Eisenberg L
    Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174
    [No Abstract]   [Full Text] [Related]  

  • 24. Stimulant drugs for severe hyperactivity in childhood.
    Drug Ther Bull; 2001 Jul; 39(7):52-4. PubMed ID: 11471516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral medications for minimal brain dysfunction in children.
    Green RP; Scales SM; Rosser PL
    J Natl Med Assoc; 1973 Mar; 65(2):157-60. PubMed ID: 4691677
    [No Abstract]   [Full Text] [Related]  

  • 26. ADHD in girls: clinical comparability of a research sample.
    Sharp WS; Walter JM; Marsh WL; Ritchie GF; Hamburger SD; Castellanos FX
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):40-7. PubMed ID: 9893415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphetamine-type drugs for hyperactive children.
    Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553
    [No Abstract]   [Full Text] [Related]  

  • 28. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
    Zametkin AJ; Karoum F; Linnoila M; Rapoport JL; Brown GL; Chuang LW; Wyatt RJ
    Arch Gen Psychiatry; 1985 Mar; 42(3):251-5. PubMed ID: 2579615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mood-altering drugs and hyperkinetic children.
    Erenberg G
    Pediatrics; 1972 Feb; 49(2):308-11. PubMed ID: 5059542
    [No Abstract]   [Full Text] [Related]  

  • 30. Stimulant drug therapy in hyperactive children: research and clinical implications.
    Wolraich ML
    Pediatrics; 1977 Oct; 60(4):512-8. PubMed ID: 333368
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationships between computer-based testing and behavioral ratings in the assessment of attention and activity in a pediatric ADHD stimulant crossover trial.
    Ramtvedt BE; Sundet K
    Clin Neuropsychol; 2014; 28(7):1146-61. PubMed ID: 25249305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of ADDH in mentally retarded children: a preliminary study.
    Payton JB; Burkhart JE; Hersen M; Helsel WJ
    J Am Acad Child Adolesc Psychiatry; 1989 Sep; 28(5):761-7. PubMed ID: 2676965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Attention in hyperkinetic children: a signal detection analysis of the effect of methylphenidate].
    Rossel E
    Z Kinder Jugendpsychiatr; 1987; 15(1):6-17. PubMed ID: 3554818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylphenidate versus dextroamphetamine in ADHD.
    Efron D
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):500. PubMed ID: 10230180
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of dextroamphetamine and methylphenidate on calcium and magnesium concentration in hyperactive boys.
    Schmidt ME; Kruesi MJ; Elia J; Borcherding BG; Elin RJ; Hosseini JM; McFarlin KE; Hamburger S
    Psychiatry Res; 1994 Nov; 54(2):199-210. PubMed ID: 7761553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The persistence of stimulant effects in chronically treated children: further evidence of an inverse relationship between drug effects and placebo levels of response.
    Gualtieri CT; Hicks RE; Mayo JP; Schroeder SR
    Psychopharmacology (Berl); 1984; 83(1):44-7. PubMed ID: 6146156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responders, nonresponders, and placebo responders among children with attention deficit disorder. Importance of a blinded placebo evaluation.
    Ullmann RK; Sleator EK
    Clin Pediatr (Phila); 1986 Dec; 25(12):594-9. PubMed ID: 3536258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S; Mohammadi MR; Khademi M
    BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of stimulant medication with children.
    Phillips S
    J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.